/NEWBRY.ST
NEWBRY.ST Stock - Newbury Pharmaceuticals AB (publ)
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$1.22+3.40%
+$0.04 (+3.40%) • Dec 23
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.68
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.34
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NEWBRY.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.20 – $1.23
TARGET (TP)$1.40
STOP LOSS$1.12
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.29
52W High$3.74
52W Low$1.13
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | $36.83M | $10.27M | $5.52M | $2.83M |
| Gross Profit | N/A | $16.03M | $3.95M | $1.56M | $460,000 |
| Gross Margin | N/A | 43.5% | 38.5% | 28.4% | 16.3% |
| Operating Income | $-20,607,000 | $-14,078,000 | $-19,587,000 | $-14,667,000 | $-5,621,000 |
| Net Income | $-20,607,000 | $-15,405,000 | $-19,431,000 | $-14,667,000 | $-5,557,000 |
| Net Margin | N/A | -41.8% | -189.3% | -265.9% | -196.4% |
| EPS | $0.00 | $-0.72 | $-1.00 | $-0.75 | $-0.35 |
Company Overview
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NEWBRY.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.26
Q2 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 31, 2025 | — | $-0.26 | — | — |
Q2 2025 | Apr 9, 2025 | — | $-0.08 | — | — |
Q1 2025 | Jan 24, 2025 | — | $-0.19 | — | — |
Q4 2024 | Oct 23, 2024 | — | $0.07 | — | — |
Q3 2024 | Jul 10, 2024 | — | $-0.39 | — | — |
Q2 2024 | Apr 10, 2024 | — | $-0.25 | — | — |
Q1 2024 | Jan 10, 2024 | — | $-0.18 | — | — |
Q4 2023 | Oct 11, 2023 | — | $-0.24 | — | — |
Q2 2023 | Jun 14, 2023 | — | $-0.21 | — | — |
Q2 2023 | Apr 12, 2023 | — | $-0.25 | — | — |
Q1 2023 | Jan 11, 2023 | — | $-0.29 | — | — |
Q4 2022 | Oct 13, 2022 | — | $-0.17 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.19 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.19 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.24 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.09 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.15 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.07 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NEWBRY.ST
What is NEWBRY.ST's current stock price?
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) is currently trading at $1.22 per share. The stock has moved +3.40% today.
What is the analyst price target for NEWBRY.ST?
No analyst price targets are currently available for this stock.
What sector is Newbury Pharmaceuticals AB (publ) in?
Newbury Pharmaceuticals AB (publ) operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is NEWBRY.ST's market cap?
Newbury Pharmaceuticals AB (publ) has a market capitalization of $0.03 billion, making it a small-cap company.
Does NEWBRY.ST pay dividends?
No, Newbury Pharmaceuticals AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACOU.ST
AcouSort AB (publ)
$2.64
Mkt Cap: $0.1B
EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ)
$16.92
Mkt Cap: $0.0B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
LPGO.ST
Lipigon Pharmaceuticals AB (publ)
$0.01
Mkt Cap: $0.0B
ODI.ST
ODI Pharma AB
$3.22
Mkt Cap: $0.1B
ONCOZ.ST
OncoZenge AB (publ)
$6.55
Mkt Cap: $0.1B
ORTI-B.ST
Ortivus AB (publ)
$1.21
Mkt Cap: $0.1B
SDOS.ST
ScandiDos AB (publ)
$1.15
Mkt Cap: $0.1B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
Explore stocks similar to NEWBRY.ST for comparison